Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
FDA Sued To Prevent Formaldehyde Exposure To Consumers, Salon Employees December 28, 2016 Russell Maas Add Your Comments Two consumer advocacy groups have filed a lawsuit against the U.S. Food and Drug Administration (FDA), after the agency failed to respond to a petition calling for certain hair products containing formaldehyde to be removed from the market. The Environmental Working Group (EWG) and Women’s Voices for the Earth filed the complaint (PDF) in the U.S. District Court for the District of Columbia on December 14, demanding a response to a 2011 formal request that the FDA remove potential allergens and human carcinogens from popular hair straightening products, indicating that they pose health hazards to both consumers and salon workers. The 2011 petition was filed by the EWG, which is an American environmental organization that specializes in research and advocacy in the areas of toxic chemicals, agricultural subsidies, public lands, and corporate accountability. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION “For years stylists have reported that the application of these hair treatments caused difficulty breathing, eye irritation and nosebleeds,” Tina Sigurdson, EWG assistant general counsel, said in a press release. “The FDA has been aware of the health hazards associated with the products since at least 2008. Despite these dangers, the FDA has yet to take action to remove them from the market.” The lawsuit was filed against the FDA for its failure to address the 2011 petition to remove or regulate the levels of formaldehyde in salon keratin hair products. According to the lawsuit, the FDA has been aware of the health hazards associated with formaldehyde exposure to humans since 2008, and despite the known dangers has refused to further regulate or remove the products from the market. Overexposure to formaldehyde can be harmful to humans with short term symptoms known to cause irritation of the eyes, nose, throat and sinuses. Other acute exposures to formaldehyde have been known to cause burning, itching, dryness and redness of the eyes, nasal dryness, soreness, sore throat, wheezing, and shortness of breath, chest pains and even bronchitis. The long-term effects of formaldehyde exposure are less known, however research over the last few decades indicates that it is a cancer-causing agent. In the early 1980’s, the U.S. Environmental Protection Agency (EPA) was notified by scientists performing independent studies that linked the exposure of formaldehyde to nasal cancer in lab rats. After analyzing the studies the EPA had classified formaldehyde as a probable human carcinogen under prolonger or extended periods of exposure. By 2011, the International Agency for Research on Cancer (IARC) had classified formaldehyde as a human carcinogen, and the National Toxicology Program of the Department of Health and Human Services (DHHS) named formaldehyde as a known and definite carcinogen to humans possible to cause cancer. Currently, the Occupational Safety and Health Administration is able to issue citations to salons where the formaldehyde levels in the air exceed permissible limits. However, after years of complaints of severe irritations reported from workers in the cosmetic industry, the FDA has yet to generate further regulation or restrict the use of formaldehyde from the products themselves. The lawsuit filed by the EWG claims the FDA failed its duty to reasonably respond to the 2011 petition and is allegedly negligent for allowing the exposure to continuously put salon workers in jeopardy for over eight years while knowing the risks. The EWG is hopeful that its lawsuit against the FDA will enforce a deadline for the agency to investigate and respond accordingly to the petition. Written by: Russell Maas Managing Editor & Senior Legal Journalist Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development. Tags: Cancer, Chemicals, Formaldehyde More Lawsuit Stories Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 December 2, 2025 Lyft Opposes MDL for Driver Sexual Assault Lawsuits in Federal Court December 2, 2025 Tesla Powerwall Recall Results in Class Action Lawsuit December 2, 2025 1 Comments DAwn December 28, 2016 Please can I be part of yr lawsuit.i have been affective X/TwitterThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (Posted: today) A federal judge has given the makers of Dupixent until January 7 to respond to a Tennessee woman’s wrongful death lawsuit. MORE ABOUT: DUPIXENT LAWSUITDupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (10/17/2025) Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: yesterday) A federal judge has scheduled a series of case management conferences throughout 2026 as the parties prepare for five “pilot” bellwether trials, which are expected to begin in late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025)Depo-Provera Pilot Lawsuit Deadlines in MDL Extended Approximately 6 Weeks (11/04/2025) Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 6 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)
Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 December 2, 2025
Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (Posted: today) A federal judge has given the makers of Dupixent until January 7 to respond to a Tennessee woman’s wrongful death lawsuit. MORE ABOUT: DUPIXENT LAWSUITDupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (10/17/2025)
Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: yesterday) A federal judge has scheduled a series of case management conferences throughout 2026 as the parties prepare for five “pilot” bellwether trials, which are expected to begin in late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025)Depo-Provera Pilot Lawsuit Deadlines in MDL Extended Approximately 6 Weeks (11/04/2025)
Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 6 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)